Compounds > spironolactone
Page last updated: 2024-08-17

spironolactone and sc 25152

spironolactone has been researched along with sc 25152 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19903 (60.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cutler, GB; Loriaux, DL; Menard, RH; Pita, JC; Rifka, SM; Sauer, MA1
Cutler, GB; Loriaux, DL; Sauer, MA1
Biollaz, M; de Gasparo, M; Grob, J; Haenni, H; Joss, U; Kraehenbuehl, C; Ramjoué, HP; Schenkel, L; Schmidlin, J; Whitebread, SE1
Baez, J; Byng, G; Laakso, JA; Mocek, UM; Preisig, CL; Wang, PT1
Ménard, J1

Other Studies

5 other study(ies) available for spironolactone and sc 25152

ArticleYear
SC 25152: A potent mineralocorticoid antagonist with reduced affinity for the 5 alpha-dihydrotestosterone receptor of human and rat prostate.
    The Journal of clinical endocrinology and metabolism, 1978, Volume: 47, Issue:1

    Topics: Aldosterone; Animals; Dihydrotestosterone; Humans; Kinetics; Male; Mineralocorticoid Receptor Antagonists; Prostate; Rats; Receptors, Androgen; Receptors, Steroid; Species Specificity; Spironolactone

1978
SC 25152: a potent mineralocorticoid antagonist with decreased antiandrogenic activity relative to spironolactone.
    The Journal of pharmacology and experimental therapeutics, 1979, Volume: 209, Issue:1

    Topics: Adrenalectomy; Androgen Antagonists; Animals; Dose-Response Relationship, Drug; Male; Mineralocorticoid Receptor Antagonists; Organ Size; Prostate; Rats; Seminal Vesicles; Spironolactone

1979
Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro.
    The Journal of pharmacology and experimental therapeutics, 1987, Volume: 240, Issue:2

    Topics: Androgen Antagonists; Animals; Biological Assay; Epoxy Compounds; Female; Male; Mineralocorticoid Receptor Antagonists; Organ Size; Ovulation; Rabbits; Rats; Receptors, Androgen; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Receptors, Progesterone; Spironolactone; Testis; Water-Electrolyte Balance

1987
Biotransformations of the cardiovascular drugs mexrenone and canrenone.
    Journal of natural products, 2003, Volume: 66, Issue:3

    Topics: Biotransformation; Canrenone; Cardiovascular Agents; Chromatography, High Pressure Liquid; Fermentation; Fungi; Magnetic Resonance Spectroscopy; Molecular Structure; Mortierella; Spironolactone; Stereoisomerism

2003
The 45-year story of the development of an anti-aldosterone more specific than spironolactone.
    Molecular and cellular endocrinology, 2004, Mar-31, Volume: 217, Issue:1-2

    Topics: Antihypertensive Agents; Cardiovascular Diseases; Chlorthalidone; Clinical Trials as Topic; Erectile Dysfunction; Female; Gynecomastia; History, 20th Century; Humans; Male; Mineralocorticoid Receptor Antagonists; Pain; Receptors, Mineralocorticoid; Spironolactone

2004